Radionuclide treatment for painful bone metastases in patients with hormone-refractory prostate cancer

被引:0
|
作者
Dolezal, J. [1 ]
机构
[1] Teaching Hosp, Hradec Kralove, Czech Republic
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S350 / S350
页数:1
相关论文
共 50 条
  • [1] Multimodality treatment in hormone-refractory prostate cancer patients with bone metastases
    Marnix G. E. H. Lam
    Bernard A. Zonnenberg
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 1394 - 1395
  • [2] Multimodality treatment in hormone-refractory prostate cancer patients with bone metastases
    Lam, Marnix G. E. H.
    Zonnenberg, Bernard A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (07) : 1394 - 1395
  • [3] Samarium-153-lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer
    Sartor, O
    Reid, RH
    Hoskin, PJ
    Quick, DP
    Ell, PJ
    Coleman, RE
    Kotler, JA
    Freeman, LM
    Olivier, P
    UROLOGY, 2004, 63 (05) : 940 - 945
  • [4] Prospective evaluation of samarium-153-EDTMP radionuclide treatment for bone metastases in patients with hormone-refractory prostate cancer
    Dolezal, J.
    Vizda, J.
    Odrazka, K.
    UROLOGIA INTERNATIONALIS, 2007, 78 (01) : 50 - 57
  • [5] Treatment of Painful Bone Metastases in Hormone-Refractory Prostate Cancer with Zoledronic Acid and Samarium-153-Ethylenediaminetetramethylphosphonic Acid Combined
    Lam, Marnix G. E. H.
    de Klerk, John M. H.
    Zonnenberg, Bernard A.
    JOURNAL OF PALLIATIVE MEDICINE, 2009, 12 (07) : 649 - 651
  • [6] Painful bone metastases in hormone-refractory prostate cancer: Economic costs of strontium-89 and/or external radiotherapy
    Malmberg, I
    Persson, U
    Ask, A
    Tennvall, J
    Abrahamsson, PA
    UROLOGY, 1997, 50 (05) : 747 - 753
  • [8] Treatment of hormone refractive prostate cancer with painful bone metastases
    Heidenreich, A
    UROLOGE-AUSGABE A, 1997, 36 (06): : 568 - 568
  • [9] Epoetin beta (NeoRecormon®) corrects anaemia in patients with hormone-refractory prostate cancer and bone metastases
    Bogdanos, J
    Karamanolakis, D
    Milathianakis, K
    Repousis, P
    Chloraki-Bobota, A
    Majed, H
    Pagalou-Thoua, E
    Tsintavis, A
    Koutsilieris, M
    ANTICANCER RESEARCH, 2004, 24 (3B) : 1957 - 1961
  • [10] Radium-223 for men with hormone-refractory prostate cancer and bone metastases
    Shelley, Mike D.
    Mason, Malcolm D.
    LANCET ONCOLOGY, 2007, 8 (07): : 564 - 565